Gisens Biotech Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Later Stage VC
- (Upcoming)
- Latest Deal Amount
-
$1.5M
- Investors
-
10
Gisens Biotech General Information
Description
Developer of a nanotechnology-based device designed to diagnose and detect renal biomarkers. The company's platform leverages nanotechnology to develop a device that diagnoses and detects renal biomarkers, enabling scientists to perform real-time and portable health monitoring to measure urea, creatinine, and potassium levels from a single blood drop and track these metrics via an application.
Contact Information
Website
www.gisensbiotech.comCorporate Office
- 2150 Shattuck Avenue
- Berkeley, CA 94704
- United States
Corporate Office
- 2150 Shattuck Avenue
- Berkeley, CA 94704
- United States
Gisens Biotech Timeline
Gisens Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | $1.5M | Upcoming | Generating Revenue | |||
| 9. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 8. Early Stage VC | 25-Dec-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Oct-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 30-Aug-2024 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 28-Aug-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 15-Jun-2023 | Completed | Product In Beta Test | |||
| 3. Accelerator/Incubator | 01-Jan-2023 | Completed | Product Development | |||
| 2. Grant | 15-Oct-2020 | $229K | $200K | Completed | Startup | |
| 1. Accelerator/Incubator | 15-Oct-2020 | $200K | $200K | Completed | Startup |
Gisens Biotech Patents
Gisens Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230236147-A1 | Sensors and systems based on field-effect transistors, methods of preparation and devices for their operation | Pending | 27-May-2020 | ||
| EP-4158327-A1 | Sensors and systems based on two-dimensional nanosheet field-effect transistors, methods of preparation and devices for their operation | Pending | 27-May-2020 | ||
| WO-2021240440-A1 | Sensors and systems based on two-dimensional nanosheet field-effect transistors, methods of preparation and devices for their operation | Inactive | 27-May-2020 | G01N27/4145 |
Gisens Biotech Signals
Gisens Biotech Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| American Heart Association | Accelerator/Incubator | |||
| Techstars | Accelerator/Incubator | |||
| Activation Capital | Accelerator/Incubator | Minority | ||
| gener8tor | Accelerator/Incubator | Minority | ||
| Berkeley SkyDeck | Accelerator/Incubator | Minority |
Gisens Biotech FAQs
-
When was Gisens Biotech founded?
Gisens Biotech was founded in 2020.
-
Where is Gisens Biotech headquartered?
Gisens Biotech is headquartered in Berkeley, CA.
-
What is the size of Gisens Biotech?
Gisens Biotech has 14 total employees.
-
What industry is Gisens Biotech in?
Gisens Biotech’s primary industry is Monitoring Equipment.
-
Is Gisens Biotech a private or public company?
Gisens Biotech is a Private company.
-
What is Gisens Biotech’s current revenue?
The current revenue for Gisens Biotech is .
-
How much funding has Gisens Biotech raised over time?
Gisens Biotech has raised $620K.
-
Who are Gisens Biotech’s investors?
American Heart Association, Techstars, Activation Capital, gener8tor, and Berkeley SkyDeck are 5 of 10 investors who have invested in Gisens Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process